Malle E - Search Results

1

Myeloperoxidase: a target for new drug development?

Malle E, Furtmüller PG, Sattler W, Obinger C. Malle E, et al. Br J Pharmacol. 2007 Nov;152(6):838-54. doi: 10.1038/sj.bjp.0707358. Epub 2007 Jun 25. Br J Pharmacol. 2007. PMID: 17592500 Free PMC article. Review.

2

Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages.

Bergt C, Reicher H, Malle E, Sattler W. Bergt C, et al. Among authors: malle e. FEBS Lett. 1999 Jun 11;452(3):295-300. doi: 10.1016/s0014-5793(99)00677-8. FEBS Lett. 1999. PMID: 10386609

3

Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-I.

Bergt C, Oettl K, Keller W, Andreae F, Leis HJ, Malle E, Sattler W. Bergt C, et al. Among authors: malle e. Biochem J. 2000 Mar 1;346 Pt 2(Pt 2):345-54. Biochem J. 2000. PMID: 10677352 Free PMC article.

4

Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.

Malle E, Waeg G, Schreiber R, Gröne EF, Sattler W, Gröne HJ. Malle E, et al. Eur J Biochem. 2000 Jul;267(14):4495-503. doi: 10.1046/j.1432-1327.2000.01498.x. Eur J Biochem. 2000. PMID: 10880973

5

Myeloperoxidase-dependent generation of hypochlorite-modified proteins in human placental tissues during normal pregnancy.

Hammer A, Desoye G, Dohr G, Sattler W, Malle E. Hammer A, et al. Among authors: malle e. Lab Invest. 2001 Apr;81(4):543-54. doi: 10.1038/labinvest.3780263. Lab Invest. 2001. PMID: 11304574

6

Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I.

Bergt C, Marsche G, Panzenboeck U, Heinecke JW, Malle E, Sattler W. Bergt C, et al. Among authors: malle e. Eur J Biochem. 2001 Jun;268(12):3523-31. doi: 10.1046/j.1432-1327.2001.02253.x. Eur J Biochem. 2001. PMID: 11422382

7

Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.

Malle E, Wäg G, Thiery J, Sattler W, Gröne HJ. Malle E, et al. Biochem Biophys Res Commun. 2001 Dec 14;289(4):894-900. doi: 10.1006/bbrc.2001.6074. Biochem Biophys Res Commun. 2001. PMID: 11735131

8

Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport.

Marsche G, Hammer A, Oskolkova O, Kozarsky KF, Sattler W, Malle E. Marsche G, et al. Among authors: malle e. J Biol Chem. 2002 Aug 30;277(35):32172-9. doi: 10.1074/jbc.M200503200. Epub 2002 Jun 17. J Biol Chem. 2002. PMID: 12070141

9

Myeloperoxidase in kidney disease.

Malle E, Buch T, Grone HJ. Malle E, et al. Kidney Int. 2003 Dec;64(6):1956-67. doi: 10.1046/j.1523-1755.2003.00336.x. Kidney Int. 2003. PMID: 14633118 Review.

10

2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis.

Marsche G, Heller R, Fauler G, Kovacevic A, Nuszkowski A, Graier W, Sattler W, Malle E. Marsche G, et al. Among authors: malle e. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2302-6. doi: 10.1161/01.ATV.0000148703.43429.25. Epub 2004 Oct 28. Arterioscler Thromb Vasc Biol. 2004. PMID: 15514213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results